WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 592232

CAS#: 303-33-3

Description: Heliotrine leads to induction of apoptosis in the human hepatoma cell line HepaRG.

Chemical Structure

CAS# 303-33-3

Theoretical Analysis

MedKoo Cat#: 592232
Name: Heliotrine
CAS#: 303-33-3
Chemical Formula: C16H27NO5
Exact Mass: 313.1889
Molecular Weight: 313.39
Elemental Analysis: C, 61.32; H, 8.68; N, 4.47; O, 25.53

Price and Availability

Size Price Availability Quantity
10.0mg USD 530.0 2 Weeks
Bulk inquiry

Synonym: AI3-51769; AI3 51769; AI351769; Heliotrine

IUPAC/Chemical Name: ((1S,7aR)-1-hydroxy-2,3,5,7a-tetrahydro-1H-pyrrolizin-7-yl)methyl (2S,3R)-2-hydroxy-2-isopropyl-3-methoxybutanoate


InChi Code: InChI=1S/C16H27NO5/c1-10(2)16(20,11(3)21-4)15(19)22-9-12-5-7-17-8-6-13(18)14(12)17/h5,10-11,13-14,18,20H,6-9H2,1-4H3/t11-,13+,14-,16+/m1/s1

SMILES Code: CC(C)[C@@]([C@H](OC)C)(O)C(OCC1=CCN2[C@@]1([H])[C@@H](O)CC2)=O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.03.00

Preparing Stock Solutions

The following data is based on the product molecular weight 313.39 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.


Dilution Calculator

Calculate the dilution required to prepare a stock solution.

1: Waizenegger J, Braeuning A, Templin M, Lampen A, Hessel-Pras S. Structure-dependent induction of apoptosis by hepatotoxic pyrrolizidine alkaloids in the human hepatoma cell line HepaRG: Single versus repeated exposure. Food Chem Toxicol. 2018 Apr;114:215-226. doi: 10.1016/j.fct.2018.02.036. Epub 2018 Feb 16. PubMed PMID: 29458164.

2: He X, Xia Q, Woodling K, Lin G, Fu PP. Pyrrolizidine alkaloid-derived DNA adducts are common toxicological biomarkers of pyrrolizidine alkaloid N-oxides. J Food Drug Anal. 2017 Oct;25(4):984-991. doi: 10.1016/j.jfda.2017.09.001. Epub 2017 Sep 19. PubMed PMID: 28987376.

3: Huybrechts B, Callebaut A. Pyrrolizidine alkaloids in food and feed on the Belgian market. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2015;32(11):1939-51. doi: 10.1080/19440049.2015.1086821. Epub 2015 Oct 15. PubMed PMID: 26373269.

4: Luckert C, Hessel S, Lenze D, Lampen A. Disturbance of gene expression in primary human hepatocytes by hepatotoxic pyrrolizidine alkaloids: A whole genome transcriptome analysis. Toxicol In Vitro. 2015 Oct;29(7):1669-82. doi: 10.1016/j.tiv.2015.06.021. Epub 2015 Jun 20. PubMed PMID: 26100227.

5: Field RA, Stegelmeier BL, Colegate SM, Brown AW, Green BT. An in vitro comparison of the cytotoxic potential of selected dehydropyrrolizidine alkaloids and some N-oxides. Toxicon. 2015 Apr;97:36-45. doi: 10.1016/j.toxicon.2015.02.001. Epub 2015 Feb 7. PubMed PMID: 25666399.

6: Shimshoni JA, Mulder PP, Bouznach A, Edery N, Pasval I, Barel S, Abd-El Khaliq M, Perl S. Heliotropium europaeum poisoning in cattle and analysis of its pyrrolizidine alkaloid profile. J Agric Food Chem. 2015 Feb 11;63(5):1664-72. doi: 10.1021/jf5052199. Epub 2015 Jan 27. PubMed PMID: 25591008.

7: Zhao Y, Wang S, Xia Q, Gamboa da Costa G, Doerge DR, Cai L, Fu PP. Reaction of dehydropyrrolizidine alkaloids with valine and hemoglobin. Chem Res Toxicol. 2014 Oct 20;27(10):1720-31. doi: 10.1021/tx5002139. Epub 2014 Sep 11. PubMed PMID: 25211425.

8: Hessel S, Gottschalk C, Schumann D, These A, Preiss-Weigert A, Lampen A. Structure-activity relationship in the passage of different pyrrolizidine alkaloids through the gastrointestinal barrier: ABCB1 excretes heliotrine and echimidine. Mol Nutr Food Res. 2014 May;58(5):995-1004. doi: 10.1002/mnfr.201300707. Epub 2013 Dec 27. PubMed PMID: 24375927.

9: Oplatowska M, Elliott CT, Huet AC, McCarthy M, Mulder PP, von Holst C, Delahaut P, Van Egmond HP, Campbell K. Development and validation of a rapid multiplex ELISA for pyrrolizidine alkaloids and their N-oxides in honey and feed. Anal Bioanal Chem. 2014 Jan;406(3):757-70. doi: 10.1007/s00216-013-7488-7. Epub 2013 Dec 11. PubMed PMID: 24327075.

10: Xia Q, Zhao Y, Von Tungeln LS, Doerge DR, Lin G, Cai L, Fu PP. Pyrrolizidine alkaloid-derived DNA adducts as a common biological biomarker of pyrrolizidine alkaloid-induced tumorigenicity. Chem Res Toxicol. 2013 Sep 16;26(9):1384-96. doi: 10.1021/tx400241c. Epub 2013 Aug 26. PubMed PMID: 23937665.

11: Tamta H, Pawar RS, Wamer WG, Grundel E, Krynitsky AJ, Rader JI. Comparison of metabolism-mediated effects of pyrrolizidine alkaloids in a HepG2/C3A cell-S9 co-incubation system and quantification of their glutathione conjugates. Xenobiotica. 2012 Oct;42(10):1038-48. doi: 10.3109/00498254.2012.679978. Epub 2012 Apr 23. PubMed PMID: 22519982.

12: Xia Q, Yan J, Chou MW, Fu PP. Formation of DHP-derived DNA adducts from metabolic activation of the prototype heliotridine-type pyrrolizidine alkaloid, heliotrine. Toxicol Lett. 2008 May 5;178(2):77-82. doi: 10.1016/j.toxlet.2008.02.008. Epub 2008 Mar 4. PubMed PMID: 18395999.

13: Cosmetic Ingredient Review Expert Panel. Final report of the safety assessment of niacinamide and niacin. Int J Toxicol. 2005;24 Suppl 5:1-31. Review. PubMed PMID: 16596767.

14: Sanderson BJ, Clark AM. Micronuclei in adult and foetal mice exposed in vivo to heliotrine, urethane, monocrotaline and benzidine. Mutat Res. 1993 Jan;285(1):27-33. PubMed PMID: 7678129.

15: Moore DJ, Batts KP, Zalkow LL, Fortune GT Jr, Powis G. Model systems for detecting the hepatic toxicity of pyrrolizidine alkaloids and pyrrolizidine alkaloid N-oxides. Toxicol Appl Pharmacol. 1989 Nov;101(2):271-84. PubMed PMID: 2815083.

16: Lieber MM, Ames MM, Powis G, Kovach JS. Anticancer drug testing in vitro: use of an activating system with the human tumor stem cell assay. Life Sci. 1981 Jan 19;28(3):287-93. PubMed PMID: 7219049.

17: Peterson JE, Jago MV. Comparison of the toxic effects of dehydroheliotridine and heliotrine in pregnant rats and their embryos. J Pathol. 1980 Aug;131(4):339-55. PubMed PMID: 7431152.

18: Evans JV, Daley SK, McClusky GA, Nielsen CJ. Direct quantitative analysis of indicine-N-oxide in cancer patient samples by gas chromatography using the internal standard heliotrine-N-oxide including a mass spectral comparison of their trimethylsilyl derivatives. Biomed Mass Spectrom. 1980 Feb;7(2):65-73. PubMed PMID: 7407334.

19: Powis G, Ames MM, Kovach JS. Relationship of the reductive metabolism of indicine N-oxide to its antitumor activity. Res Commun Chem Pathol Pharmacol. 1979 Jun;24(3):559-69. PubMed PMID: 451340.

20: Evans JV, Peng A, Nielsen CJ. The gas chromatographic mass spectrometric analysis of the new antitumor drug indicine-N-oxide utilizing a novel reaction accompanying trimethylsilylation. Biomed Mass Spectrom. 1979 Jan;6(1):38-43. PubMed PMID: 427260.